THERESA WATTS: Open Payments
NPI 1225318645 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147,311 in 344 payments from 10 companies in 2025. Trend: 2023 $155,424 · 2024 $141,352 · 2025 $147,311
Speaker / faculty: $120,750Travel & lodging: $20,502Food & beverage: $6,059
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 284 | $146,303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $248 |
| Vanda Pharmaceuticals Inc. | 16 | $226 |
| Teva Pharmaceuticals USA, Inc. | 6 | $110 |
| Neurocrine BioSciences, Inc. | 5 | $98 |
| Alkermes, Inc. | 4 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $28 |
Products named: VRAYLAR, CAPLYTA, HETLIOZ, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
